文献速递神经肌肉病

定量肌肉超声可检测杜氏肌营养不良疾病进展

Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy.
PubMed 文献 · Ann Neurol · 2017-05-04

研究纳入36例DMD男孩和28例健康男孩,随访至2年,比较灰度水平(GSL)和定量背散射分析(QBA)与功能评估的轨迹。结果显示超声指标在DMD男孩中比功能测试更早发现肌肉恶化,但未显示皮质类固醇起始的影响。

要点

  • 定量肌肉超声在DMD男孩中可检测疾病进展,且早于功能评估。
  • GSL和QBA表现相似,均较功能测试敏感。
  • 超声未显示皮质类固醇起始的效应。

核心结论

  • QBA与GSL表现相似,两者在检测DMD肌肉恶化方面均比功能评估更敏感。

研究设计与样本

  • 研究纳入36例DMD男孩和28例健康男孩,年龄2-14岁,随访至2年,从6块单侧手臂/腿部肌肉获取GSL和QBA。
  • 采用线性混合效应模型比较GSL、QBA和功能评估的轨迹,并单独分析开始皮质类固醇治疗的男孩亚组。

主要发现

  • 在>7.0岁的DMD男孩中,GSL增加首次在6个月时被识别,例如前臂斜率差异为1.16任意单位/月,p=0.004,95%CI=0.38-1.94。
  • 在≤7岁的DMD男孩中,GSL差异首次出现在12个月,例如股直肌为0.82任意单位/月,p=0.04,95%CI=0.075-1.565。
  • QBA表现与GSL相似,例如>7岁DMD男孩前臂在6个月时为0.41dB/月,p=0.01,95%CI=0.096-0.72。
  • 超声识别差异早于功能测量,包括6分钟步行和仰卧起坐测试。
  • QBA或GSL均未显示皮质类固醇起始的效应。

临床怎么用

  • 定量肌肉超声可作为DMD疾病进展的生物标志物,较功能评估更早提示肌肉恶化。
  • 需进一步研究确定定量肌肉超声能否检测治疗效果。

局限性

  • 需额外研究确定定量肌肉超声能否检测治疗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We assessed changes in quantitative muscle ultrasound data in boys with Duchenne muscular dystrophy (DMD) and healthy controls to determine whether ultrasound can serve as a biomarker of disease progression. Two approaches were used: gray scale level (GSL), measured from the ultrasound image, and quantitative backscatter analysis (QBA), measured directly from the received echoes. METHODS: GSL and QBA were obtained from 6 unilateral arm/leg muscles in 36 boys with DMD and 28 healthy boys (age = 2-14 years) for up to 2 years. We used a linear mixed effects model with random intercept and slope terms to compare trajectories of GSL, QBA, and functional assessments. We analyzed separately a subset of boys who initiated corticosteroids. RESULTS: Compared to healthy boys, increasing GSL in DMD boys >7.0 years old was first identified at 6 months (eg, anterior forearm slope difference of 1.16 arbitrary units/mo, p = 0.004, 95% confidence interval [CI] = 0.38-1.94); in boys ≤ 7 years old, differences in GSL first appeared at 12 months (0.82 arbitrary units/mo, p = 0.04, 95% CI = 0.075-1.565, in rectus femoris). QBA performed similarly to GSL (eg, DMD boys > 7 years old: 0.41dB/mo, p = 0.01, 95% CI = 0.096-0.72, in anterior forearm at 6 months). Ultrasound identified differences earlier than functional measures including 6-minute walk and supine-to-stand tests. However, neither QBA nor GSL showed an effect of corticosteroid initiation. INTERPRETATION: QBA performs similarly to GSL, and both appear more sensitive than functional assessments for detecting muscle deterioration in DMD. Additional studies will be required to determine whether quantitative muscle ultrasound can detect therapeutic efficacy. Ann Neurol 2017;81:633-640.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Zaidman CM, Wu JS, Kapur K, et al. Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy. Ann Neurol. 2017. PMID: 28241384. doi:10.1002/ana.24904

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。